Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE)
- de Haas, S.L.
- Slamon, D.J.
- Martin, M.
- Press, M.F.
- Lewis, G.D.
- Lambertini, C.
- Prat, A.
- Lopez-Valverde, V.
- Boulet, T.
- Hurvitz, S.A.
ISSN: 1465-542X
Argitalpen urtea: 2023
Alea: 25
Zenbakia: 1
Orrialdeak: 2
Mota: Artikulua